| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NOVAVAX INC | President, R&D | Common Stock | 66,613 | $968,553 | $14.54 | 17 Jun 2024 | Direct |
| NOVAVAX INC | President, R&D | Stock Option (Right to Buy) | 37,500 | $228,375 | $6.09 | 17 Jun 2024 | Direct |
| NOVAVAX INC | President, R&D | Restricted Stock Units | 5,376 | $29,299 | $5.45 | 10 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NVAX | NOVAVAX INC | 17 Jun 2024 | 6 | -$201,164 | 4 | President, R&D | 20 Jun 2024, 17:08 |
| NVAX | NOVAVAX INC | 14 May 2024 | 3 | -$520,662 | 4 | President, R&D | 15 May 2024, 21:15 |
| NVAX | NOVAVAX INC | 10 Mar 2024 | 3 | -$14,154 | 4 | President, R&D | 12 Mar 2024, 20:46 |
| NVAX | NOVAVAX INC | 07 Mar 2024 | 3 | -$52,689 | 4 | President, R&D | 11 Mar 2024, 21:40 |
| NVAX | NOVAVAX INC | 01 Mar 2024 | 1 | $0 | 4 | President, R&D | 26 Mar 2024, 19:00 |
| NVAX | NOVAVAX INC | 14 Dec 2023 | 3 | +$8,336 | 4 | President, R&D | 18 Dec 2023, 17:00 |
| NVAX | NOVAVAX INC | 05 Nov 2023 | 3 | +$5,104 | 4 | President, R&D | 07 Nov 2023, 17:30 |
| NVAX | NOVAVAX INC | 16 Sep 2023 | 3 | +$50,393 | 4 | President, R&D | 19 Sep 2023, 17:16 |
| NVAX | NOVAVAX INC | 16 Jun 2023 | 3 | +$17,270 | 4 | President, R&D | 21 Jun 2023, 16:40 |
| NVAX | NOVAVAX INC | 16 Jun 2023 | 0 | $0 | 3 | President, R&D | 21 Jun 2023, 16:39 |